21493 ⎘
Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier; Organic compounds; Peptides, e.g. proteins Antibodies; Immunoglobulins; Fragments thereof
MULTI-MODAL MOLECULAR IMAGING NANOPROBE FOR EARLY WARNING AND DYNAMIC MONITORING OF ATHEROSCLEROTIC PLAQUES AND USE THEREOF
#2THERAPEUTIC AGENTS AND USES THEREOF
#3SINGLE-DOMAIN HIGH AFFINITY ANTIBODIES AND METHODS OF USE THEREOF
#4Treatment and Prophylaxis of Amyloidosis
#5ANTI-PSMA ANTIBODIES, VARIANTS, AND USES THEREOF
#6ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF
#7TISSUE-SPECIFIC MANGANESE BASED MRI CONTRAST AGENTS
#8Anti-TSLP nanobodies and their applications
#9BIOCOMPATIBLE IMAGING PARTICLES, THEIR SYNTHESIS AND USE IN IMAGING TECHNIQUES
#10PSMA-TARGETED NIR DYES AND THEIR USES
#11ANTIGEN BINDING MOLECULES AND METHODS OF USE
#12POROUS NANOCARRIERS FOR THE MONITORING AND TREATMENT OF BLADDER CANCER
#13NOVEL PROTEIN SPECIFICALLY BINDING TO CALRETICULIN AND HAVING HUMAN FIBRONECTIN DOMAIN III SCAFFOLD AND USE THEREOF
#14SELF-ASSEMBLED BIOCOMPATIBLE IMAGING PARTICLES, THEIR SYNTHESIS AND THEIR USE IN IMAGING TECHNIQUES
#15NOVEL SINGLE DOMAIN ANTIGEN BINDING MOLECULES AND THEIR USES
#16PRECISE LABELING OF PROTEIN SCAFFOLDS WITH CARGO FOR USE IN BIOMEDICAL APPLICATIONS
#17ACTIVE DELIVERY OF RADIOTRACERS ACROSS THE BLOOD BRAIN BARRIER
#18MONOCLONAL ANTIBODIES AGAINST PATHOLOGICAL TAU, AND METHODS USING SAME
#19CELL SORTING MICROBEADS AS NOVEL CONTRAST AGENT FOR MAGNETIC RESONANCE IMAGING
#20THERANOSTIC SYSTEM FOR DIRECTED DIFFUSION OF THERAPEUTIC AND IMAGING AGENTS TO CANCER CELLS
#21MICROPARTICLE COMPOSITIONS
#22TARGETED PROTEIN CONTRAST AGENTS, METHODS OF MAKING, AND USES THEREOF
#23CROSS-LINKING COMPOUNDS AND METHODS OF USE THEREOF
#24METHOD FOR DIAGNOSTICALLY IMAGING LESIONS IN THE PERIPHERAL NERVOUS SYSTEM
#25Anti-complement C1s antibodies and uses thereof
#26COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY
#27THERAPEUTIC AGENTS AND USES THEREOF
#28PSMA-TARGETED NIR DYES AND THEIR USES
#29CONJUGATE COMPRISING LIGAND, SPACER, PEPTIDE LINKER, AND BIOMOLECULE
#30CONJUGATE COMPRISING LIGAND AND CEACAM5 ANTIBODY FAB FRAGMENT
#31C-terminal lysine conjugated immunoglobulins
#32Human antibodies, pharmaceutical compositions and methods
#33Porous nanocarriers for the monitoring and treatment of bladder cancer
#34Conjugated biological molecules, pharmaceutical compositions and methods
#35PSMA-targeted NIR dyes and their uses
#36Targeted protein contrast agents, methods of making, and uses thereof
#37Periostin antibodies and methods of using the same
#38Treatment and Prophylaxis of Amyloidosis
#39Targeted protein contrast agents, methods of making, and uses thereof
#40Anti-C3d antibody conjugates and methods of detecting complement activation
#41Humanized antibodies that recognize alpha-synuclein
#42Use of radiolabeled nanobody in prognosis and diagnosis of cancer
#43HUMAN ANTI-TAU ANTIBODIES
#44Anti-human MUC1 antibody Fab fragment
#45Detection, Measurement, And Imaging Of Cells Using Cellular Internalization of Nanoparticles
#46NOVEL ANTI-HUMAN MUC1 ANTIBODY FAB FRAGMENT
#47Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
#48THERAPEUTIC AGENTS AND USES THEREOF
#49Modified variable domain molecules and methods for producing them
#50ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF
#51FOXC1 ANTIBODIES AND METHODS OF THEIR USE
#52TDP-43 specific binding molecules
#53C-terminal lysine conjugated immunoglobulins
#54Antibody specifically binding to PD-1 and functional fragment thereof
#55POLYMALIC ACID BASED NANOCONJUGATES FOR IMAGING
#56Squalene epoxidase in the diagnosis and treatment of non-alcoholic fatty liver diseases
#57Antibody specifically binding to IL-17A, encoding nucleic acid, and method of using the antibody
#58Compounds and methods for the detection of TRPV-6 cancers and drug delivery
#59HUMAN ANTI-TAU ANTIBODIES
#60Humanized antibodies that recognize alpha-synuclein
#61PSMA-targeted NIR dyes and their uses
#62Monoclonal antibody therapy for pancreas cancer
#63Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
#64Antibody binding to HEG1 and use of the antibody for detection and treatment of mesothelioma
#65Reporter platform for real time monitoring of drug efficacy
#66PAMAM dendrimer based CEST imaging agents and uses thereof
#67BLOOD-BRAIN BARRIER VECTOR COMPOUNDS AND CONJUGATES THEREOF
#68Blood-brain barrier permeable peptide compositions comprising a VAB domain of an anti-amyloid-beta camelid single-domain heavy-chain only antibody
#69Human anti-alpha-synuclein antibodies
#70TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#71MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer
#72Cyanine compounds
#73Targeted protein contrast agents, methods of making, and uses thereof
#74DNA molecules encoding antibodies to tau and methods of making thereof
#75ANTI-HUMAN FOLATE RECEPTOR BETA ANTIBODIES AND METHODS OF USE
#76Conjugated biological molecules, pharmaceutical compositions and methods
#77MONOAMINE OXIDASE INHIBITORS AND METHODS FOR TREATMENT AND DIAGNOSIS OF PROSTATE CANCER
#78Tumor Deliverable Iron and Protein Synthesis Inhibitors as a New Class of Drugs for the Diagnosis and Treatment of Cancer
#79Humanized antibodies that recognize alpha-synuclein
#80HUMAN ANTI-TAU ANTIBODIES
#81TEM8 antibodies and their use in treatment and detection of tumors
#82PSMA—targeted NIR dyes and their uses
#83PSMA-targeted NIR dyes and their uses
#84ISOLATED ANTI-MESOTHELIN ANTIBODIES, CONJUGATES AND USES THEREOF
#85MODIFIED VARIABLE DOMAIN MOLECULES AND METHODS FOR PRODUCING THEM
#86Anti-complement C1s antibodies
#87MONOCLONAL ANTIBODY THERAPY FOR PANCREAS CANCER
#88TDP-43 specific binding molecules
#89CYANINE COMPOUNDS
#90COMPOSITION FOR TARGET SUBSTANCE DETECTION COMPRISING MAGNETIC NANOPARTICLE HAVING A CURIE TEMPERATURE WHICH IS WITHIN BIOCOMPATIBLE TEMPERATURE RANGE AND SYSTEM FOR TARGET SUBSTANCE DETECTION
#91PSMA-targeted NIR dyes and their uses
#92PSMA-targeted NIR dyes and their uses
#93Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
#94MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer
#95Oligopeptide and methods for producing conjugates thereof
#96Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof
#97MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer
#98TEM8 antibodies and their use in treatment and detection of tumors
#99Humanized antibodies that recognize alpha-synuclein
#100FC RECEPTOR BINDING PROTEINS
#101Anti-human folate receptor beta antibodies and methods of use
#102Method for quantifying the characteristics of an object treated with a contrast agent
#103Labeled ligands of anti-Mullerian hormone for diagnosis of endometriosis
#104Cyanine compounds
#105Methods and apparatuses for the localization and treatment of disease such as cancer
#106Methods of inhibiting complement C4 activation with anti-complement C1s antibodies
#107Methods and compositions for radiohalogen protein labeling
#108Human anti-tau antibodies
#109Manganese-based magnetic resonance contrast agents
#110MANGANESE-BASED MAGNETIC RESONANCE CONTRAST AGENTS
#111Method and device for producing crude copper
#112HUMAN ANTI-ALPHA-SYNUCLEIN ANTIBODIES
#113Sulfonic esters of metal oxides and methods of their use
#114Compounds and methods for the detection of TRPV-6 cancers and drug delivery
#115Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#116Contrast agent for nuclear magnetic resonance imaging comprising melanin nanoparticles stably dispersed in water
#117Anti-human folate receptor beta antibodies and methods of use
#118FOXC1 ANTIBODIES AND METHODS OF THEIR USE
#119Antibodies for molecular imaging of vulnerable plaques in atherosclerosis
#120Treating macular degeneration using antibodies to aminophospholipids
#121Therapeutic agents and uses thereof
#122Single chain antibodies that specifically bind to the activated state of the platelet integrin receptor GP IIb/IIIa
#123Methods of treating a tauopathy
#124Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#125Methods and compositions for radiohalogen protein labeling
#126TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#127MAGNETIC RELAXOMETRY USING MAGNETIZATION AND MEASUREMENT FIELDS
#128In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
#129NANOPARTICLE MEDIATED GENE THERAPY, DIAGNOSTIC PRODUCTS AND THERAPEUTIC PRODUCTS FOR BREAST CANCER
#130COMPOUND
#131In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
#132Pretargeting kit, method and agents used therein
#133Compositions useful for target, detection, imaging and treatment, and methods of production and use thereof
#134Anti-human folate receptor beta antibodies and methods of use
#135Anti-human transferrin receptor antibody and uses thereof
#136Method for diagnostically imaging lesions in the peripheral nervous system
#137METHODS AND COMPOSITIONS FOR DIAGNOSIS OF IGA-AND IGM-MEDIATED KIDNEY DISEASES
#138FC RECEPTOR BINDING PROTEINS
#139TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#140Reporter vector presenting extracellular binding capacity to metallic compounds
#141Polymalic acid based nanoconjugates for imaging
#142FOXC1 ANTIBODIES AND METHODS OF THEIR USE
#143Detection of amyloid deposits using anti-amyloid antibodies
#144MULTIDOMAIN BIOTAGS FOR CANCER DETECTION, DIAGNOSIS AND THERAPY AND METHODS OF THEIR USE
#145MOLECULAR DEATH TAGS AND METHODS OF THEIR USE
#146METHODS FOR IN VIVO CANCER DETECTION, DIAGNOSIS AND THERAPY USING MULTIDOMAIN BIOTAGS
#147METHODS FOR IN VITRO CANCER CELL DETECTION, DIAGNOSIS AND THERAPY USING MULTIDOMAIN BIOTAGS
#148In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
#149Anti-amyloid antibodies
#150Monoclonal antibody therapy for pancreas cancer
#151Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis corresponding compositions and kits
#152Human anti-alpha-synuclein antibodies
#153Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticles
#154TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#155Chimeric, humanized, or human antibody 2A4
#156Monoclonal antibody therapy for pancreas cancer
#157METHOD OF TREATING IMMUNE DISEASE USING B-CELL ANTIBODIES
#158ELEMENTAL IRON NANOPARTICLES
#159Compound
#160IN VIVO IMAGING
#161Treatment and prophylaxis of amyloidosis
#162COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY
#163METHOD FOR IMAGING TUMOR TISSUE
#164Imaging of Activated Vascular Endothelium Using Immunomagnetic MRI Contrast Agents
#165USE OF MRI CONTRAST AGENTS FOR EVALUATING THE TREATMENT OF TUMORS
#166Polylysine dendrimer contrast agent
#167Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof
#168DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS
#169Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
#170Fc receptor binding proteins
#171ANTICOAGULATION AGENT AND USES THEREOF
#172Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis, corresponding compositions and kits
#173Targeted Nanostructures for Cellular Imaging
#174Chimeric, humanized, or human antibody 2A4
#175Anticoagulation Agent and Uses Thereof
#176Sensor permitting detection of a substance in the body of a living being
#177METHOD AND CONTRAST AGENT FOR IMAGING A PROSTATE TUMOR
#178Chelating agents with lipophilic carriers
#179Fragments of antibodies to epidermal growth factor receptor and methods of their use
#180ISOLATION OF ANTIBODIES THAT CROSS-REACT AND NEUTRALIZE RANKL ORIGINATING FROM MULTIPLE SPECIES
#181Monoclonal antibody therapy for pancreas cancer
#182VEGF-conjugate combined methods for tumor vasculature targeting and tumor treatment
#183Cancer treatment kits using antibodies to aminophospholipids
#184Method of affecting a function of or ablating a non-malignant cell
#185Novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
#186Method of diagnosing, monitoring, staging, imaging and treating cancer
#187Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer
#188Imaging the activity of extracellular protease in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases
#189Diagnosis and treatment of malignant neoplasms
#190Labeled ligands for lectin-like oxidized low-density lipoprotein receptor (LOX-1)